(Bloomberg) — Covid antibodies in patients with mild symptoms fade quickly, raising concerns that their immunity from a future infection may not last very long, researchers said in the New England Journal of Medicine.
The U. S. charged two Chinese hackers with working for China’s Ministry of State Security to steal coronavirus research from Western companies. European regulators are preparing for the possibility of approving a vaccine this year after a flurry of promising results, even as comments from the U.
K.’s chief medical officer reflected uncertainty in the scientific community.
California reported slowing growth in hospitalizations, while President Donald Trump’s administration officials and congressional leaders are poised to start talks on another U. S. stimulus plan.
Key Developments:
- Global Tracker: Cases pass 14.7 million; deaths top 611,000
- Double-shot vaccine tests present new challenge
- Trump makes sudden push for mask wearing, to resume briefings
- Economists say $1 trillion needed to avert U.
S. disaster
- Seniors weigh long-term care plans against Covid-19 risks
- The inside story of how Europe landed its massive stimulus plan
- Covid-19 threatens to undo women’s economic progress, IMF says
Subscribe to a daily update on the virus from Bloomberg’s Prognosis team here. Click CVID on the terminal for global data on coronavirus cases and deaths.
Florida Creates Nursing Homes for Virus Patients (1:15 p.m.
NY)
Florida officials are trying to ease pressure on the health-care system by creating a network of nursing homes for people who have Covid-19 but aren’t sick enough to be hospitalized. The state now has about 1,400 beds where elderly Covid-positive patients can be isolated without taking up a bed in a hospital, said Governor Ron DeSantis.
“We cannot allow a contagious patient to be sent back into a long-term care facility that doesn’t have the capability to appropriately isolate them,” DeSantis said at a roundtable discussion about Covid-19 in Tallahassee. “It’s also helpful for hospitals to manage caseloads.”
New York Governor Andrew Cuomo has been criticized for a March directive forcing nursing homes to accept patients released from hospitals who were infected with Covid-19.
Antibodies Fade Quickly, NEJM Report Says (12:20 p.m.
NY)
Covid antibodies in patients with mild symptoms fade quickly, raising concerns that their immunity from a future infection may not last very long, researchers said in the New England Journal of Medicine.
The first analysis was done on antibodies taken an average of 37 days after symptoms began, with a second after about 86 days, or less than three months. The researchers determined that antibody levels had fallen precipitously, with a half-life of about 73 days between the two time frames.
That raises concern that immunity may not last long in people who develop a mild infection, which accounts for the majority of cases.
The results call for caution regarding antibody-based “immunity passports,” herd immunity and perhaps vaccine durability, especially in light of short-lived immunity against common human coronaviruses, according to the researchers led by F. Javier Ibarrondo, from the David Geffen School of Medicine at the University of California Los Angeles.
N.
Y. Quarantine List Grows to 31 States (12:08 p.m. NY)
Ten states were added to New York’s quarantine list and one was removed, for a new total of 31, Governor Andrew Cuomo said: Alaska, Delaware, Indiana, Maryland, Missouri, Montana, North Dakota, Nebraska, Virginia and Washington. Minnesota was removed.
Cuomo said he’s looking at potentially adding territories, such as Puerto Rico, to the mandatory quarantine list.
The advisory is based on a seven-day rolling average of the number of positive tests in excess of 10%, or the number of positive cases exceeding 10 per 100,000 residents.
Cases Much Higher Than Reported, CDC Says (11:55 a.m. NY)
The number of people infected with the coronavirus in parts of the U. S. is as much as 13 times higher than the reported rates in those regions, the New York Times reported, citing data released Tuesday by the Centers for Disease Control and Prevention.
The findings suggest that many people who didn’t show symptoms or seek medical care may have kept the virus in circulation, the Times said.
Florida Hospitalizations Set Daily Record (10:55 a.m. NY)
Cumulative hospitalizations of Florida residents rose 2.4%, to 21,780. The daily increase of 517 is the most on record, according to data compiled by Bloomberg.
Austria Tightens Restrictions (10:05 a.m.
NY)
Austria is tightening measures against the spread of the novel coronavirus again, dialing back part of its easing in the past few weeks as new infections have surged in various clusters. Border controls will tighten because a significant share of infections are coming from travelers returning from Balkan countries such as Serbia and Romania. Face masks will again be required in supermarkets, banks and post offices.
Tokyo to Urge Residents to Stay Home Over Weekend (8:33 a.m.
NY)
Tokyo Governor Yuriko Koike is considering urging residents to avoid unnecessary trips outdoors during a forthcoming four-day weekend. The holiday was originally scheduled to celebrate the start of the Tokyo Olympic Games, now postoponed until 2021.
Daily coronavirus cases in the Japanese capital rose are back above 200, with 237 cases reported on Tuesday. Tokyo has now seen more than 1,600 infections in the past week, while hospitalizations have risen almost fivefold in the past month.
Dutch Cases Nearly Double on Weekly Basis (8:10 a.m.
NY)
Almost 1,000 new infections were reported in the Netherlands last week, according to the health agency RIVM. The total of 987 positive tests was almost double the amount from a week earlier. The percentage of tests coming back positive has increased, a further sign of a resurgence, RIVM said. The reproduction factor — or R value — rose to 1.29. A number below 1.0 is seen as preventing exponential growth in the number of cases and a second wave of infections.
First Vaccine May Be Approved in 2020: EU Regulator (8:02 a.m.
NY)
European regulators could approve the first vaccine against Covid-19 this year, after a flurry of trials by drugmakers leading the race showed promising results.
“We are preparing ourselves for that possibility so that we as regulators will be ready,” Marco Cavaleri, head of anti-infectives and vaccines at the European Medicines Agency, said in an interview Tuesday. “It will be a matter of seeing whether this data could be sufficient for allowing any kind of approval by the end of 2020.”
Separately, U.
K. Prime Minister Boris Johnson’s senior medical adviser, Chris Whitty, said there is only a slim chance of an effective vaccine being available by Christmas, even as the University of Oxford reported progress on its initiative.
Hong Kong Denies Lockdown Speculation (7:26 a.m. NY)
Hong Kong’s government said speculation the city would be locked down in coming days was false after reporting 58 additional local cases on Tuesday, 24 of which were of unknown origins.
The Asian financial hub has been taken off-guard by the sudden eruption of infections, close to half of which are untraceable.
While other places in the region like Australia are also facing aggressive resurgences, their hospital bed vacancies and testing capabilities appear to outstrip those of Hong Kong’s.
U. K. Budget Deficit Swells on Stimulus (7:20 a.m. NY)
U. K. government borrowing soared to almost 130 billion pounds ($165 billion) in the first three months of the fiscal year amid the towering cost of supporting the economy through the coronavirus crisis.
The Office for National Statistics said Tuesday that the budget deficit stood at 35.5 billion pounds in June alone, leaving debt at almost 100% of GDP.
Chancellor Rishi Sunak fired the starting gun on a comprehensive review of government spending for the coming years, warning of “tough choices” for some departments.
Indonesia to Start Vaccine Trial (7:02 a.m. NY)
PT Bio Farma, an Indonesian state-owned drugmaker, plans to start human trials of Sinovac Biotech Ltd.’s vaccine next month and aims to begin commercial production early next year.
The country tied up with Beijing-based Sinovac to secure access to a vaccine as its own efforts to develop a deterrent against the pathogen is expected to take longer.
The world’s fourth-most populous nation is the worst virus-hit country in Southeast Asia, with a death toll of 4,320 and confirmed cases nearing 90,000.
Oman Restricts Movement, Iran Deaths (6:04 a.m. NY)
Oman is restricting movement between provinces and closing public places and shops overnight after reporting its third-highest number of new cases. The regional travel restrictions start July 25 and will last for two weeks.
Gatherings and collective celebrations of all kind are also banned, the Times of Oman reported.
Meanwhile, Iran saw its highest number of coronavirus fatalities in one day at 229 in the past 24 hours, taking the death toll to 14,634.
Israel Keeps Restaurants, Beaches Open (5:47 p.m. HK)
An Israeli parliamentary panel voted to keep beaches open on weekends and preserve restaurant dining, overriding Prime Minister Benjamin Netanyahu, who said those venues needed to be placed off limits to prevent a second lockdown.
Nearly a Quarter of New Delhi’s Population Have Had Covid-19 (5:16 p.m.
HK)
Nearly a quarter of the residents in India’s capital New Delhi have had the coronavirus, according to a sero-prevalence study conducted by the country’s disease control organization.
The study conducted by the National Center for Disease Control found that 23.48% of the 21,387 blood samples tested showed the prevalence of IgG antibodies. With a population of more than 11 million, New Delhi has so far reported 123,747 confirmed cases and 3,663 deaths.
Russian Military Touts Incomplete Vaccine (4:20 p.m.
HK)
A vaccine developed with the Russian Defense Ministry completed Phase 2 trials, leading First Deputy Defense Minister Ruslan Tsalikov to say the first domestic inoculation is ready for use.
A second group of volunteers ended Phase 2 trials Monday, with everyone developing immunity from the coronavirus and feeling fine, Tsalikov said in an interview with Argumenty i Fakty newspaper, published Tuesday.
He didn’t say when Phase 3 large-scale trials would take place or when production of the vaccine may begin.
“They’re all getting ahead of themselves,” said Sergei Netesov, a former executive at Vector, a state-run virology center in Novosibirsk that’s also working on an inoculation. “The third phase has not started yet, or even been announced. The reason they’re in such a rush is completely incomprehensible.”
Germany’s Infection Rate Declines (1:40 p.m.
HK)
Germany recorded a slight increase in the number of new coronavirus cases amid an easing in the country’s infection rate. There were 590 new cases in the 24 hours through Tuesday morning, bringing the total to 203,325, according to data from Johns Hopkins University. The reproduction factor of the virus declined to 1.15 on Monday, from 1.25 the day before, according to the latest estimate from the Robert Koch Institute.
For more articles like this, please visit us at bloomberg.com
©2020 Bloomberg L.
P.
